Skip to main content
. Author manuscript; available in PMC: 2015 Sep 3.
Published in final edited form as: Invest New Drugs. 2010 Feb 12;29(4):680–687. doi: 10.1007/s10637-010-9396-4

Table 5.

Acne lesion count (ALC) and global acne grading system (GAGs) and response

Dose level ALC baseline/cycle 1/cycle 2 GAGs baseline/cycle 1/cycle 2 CTCAE V3.0 grade of rash cycle 1/cycle 2 Best response
0 0/149 0/22 2 PD
0 0/301/275 0/32/33 2/2 SD
0 0/46 0/23 2 PD
1 0 0 0 PD
1 0 0 1 PD
1 0/69/119 0/6/33 2/2 SD
2 0/59 0/27 2 NE
2 159/998/1773 9/33/33 3/3 PD
2 0/137/418 0/33/33 2/2 PD
3 0/67 0/27 2 PD
3 0 0 2 SD
3 0/0 0/0 2 PD
3 0/83 0/24 2 PD
3 0/223 0/21 2 PD
3 0/26 0/2 2 PD
3 0 0 1 SD
3 0/20 0/24 1 PD
3 0 0 1 PD
3 0/36 0/21 2 SD
3 0/3 0/3 2 NE
3 0 0 0 NE
3 0/216 0/27 1 NE
3 0/0 0/0 0 SD
3 0/87 0/33 2 SD